[ad_1]


. 2022 Oct 21;101(42):e31159.


doi: 10.1097/MD.0000000000031159.

Affiliations

Item in Clipboard

Shan HuĀ et al.


Medicine (Baltimore).


.

Abstract

To analyze the expression and prognostic value of paired-box 8 (PAX8) expression in uterine corpus endometrial carcinoma (UCEC) by bioinformatics. The expression of PAX8 gene in UCEC was analyzed by R language and immunohistochemistry. The correlation between PAX8 expression and clinicopathological features was analyzed by R language. The prognostic factors was analyzed by univariate/multivariate regression. The survival curve of patients was analyzed by Kaplan-Meier Plotter (K-M Plotter). The diagnostic value of PAX8 in UCEC was analyzed by receiver operating characteristic curve, and the relationship between PAX8 expression and methylation was analyzed by Ualcan. The relationship between methylation and prognosis was analyzed by MethSurv database. The expression of PAX8 in cancer tissues was significantly higher than that in normal tissues. The expression of PAX8 was related to clinical stage, age, histological type, histologic grade, tumor invasion and disease-specific survival event. Univariate/multivariate regression analysis showed that clinical stage, tumor invasion, and PAX8 expression were the influence factors of overall survival (OS), while histologic grade and PAX8 expression were the influence factors of disease-specific survival, and patients with low expression had a longer OS. The area under the curve of receiver operating characteristic curve was 0.81 for PAX8 diagnosis of UCEC. PAX8 was hypomethylated in cancer tissue, and patients with hypermethylated PAX8 had a longer OS. The high expression of PAX8 induced by hypomethylation may play an important role in the occurrence and prognosis of UCEC.

Conflict of interest statement

The authors have no conflicts of interest.

References

    1. Berger AA, Dao F, Levine DA. Angiogenesis in endometrial carcinoma: therapies and biomarkers, current options, and future perspectives. Gynecol Oncol. 2021;160:844ā€“50.

    1. Huvila J, Pors J, Thompson EF, et al. Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis. J Pathol. 2021;253:355ā€“65.

    1. Arakawa T, Fukuda S, Hirata T, et al. PAX8: a highly sensitive marker for the glands in extragenital endometriosis. Reprod Sci. 2020;27:1580ā€“6.

    1. Jeong JH, Kim NY, Pyo JS. Analysis of PAX8 immunohistochemistry in lung cancers: a meta-analysis. J Pathol Transl Med. 2020;54:300ā€“9.

    1. Adler EK, Corona RI, Lee JM, et al. The PAX8 cistrome in epithelial ovarian cancer. Oncotarget. 2017;8:108316ā€“32.